200,000+ products from a single source!
sales@angenechem.com
408340-16-9 | 2,3-DIIODOPHENOL
CAS No: 408340-16-9 Catalog No: AG00C7JM MDL No:
Product Description
Catalog Number:
AG00C7JM
Chemical Name:
2,3-DIIODOPHENOL
CAS Number:
408340-16-9
IUPAC Name:
2,3-diiodophenol
InChI:
InChI=1S/C6H4I2O/c7-4-2-1-3-5(9)6(4)8/h1-3,9H
InChI Key:
YPJVJVIQWWXEHO-UHFFFAOYSA-N
Properties
Complexity:
97.1
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
345.835g/mol
Formal Charge:
0
Heavy Atom Count:
9
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
345.906g/mol
Monoisotopic Mass:
345.835g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
20.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.9
Literature
| Title | Journal |
|---|---|
| Expression of enzymatically inactive wasp venom phospholipase A1 in Pichia pastoris. | PloS one 20110101 |
| Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors. | PloS one 20090101 |
| A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. | Clinical cancer research : an official journal of the American Association for Cancer Research 20061101 |
| Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT). | British journal of cancer 20040614 |
| Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK. | British journal of cancer 20030804 |
Related Products
© 2019 Angene International Limited. All rights Reserved.